Delivery Order SPE2DR25D1034-SPE2DR26FPW7B
- Not listed
- The Defense Logistics Agency awarded a $1,455.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on October 28, 2025, with completion scheduled for November 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits under a firm fixed-price contract with a ceiling value of $2,911.28. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,169.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of December 31, 2025. This non-set-aside contract was competitively awarded on December 9, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order was issued without set-aside restrictions and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be performed at the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $1,584.52 and an ultimate completion date of January 2, 2026. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of October 7, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,338.08 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $12,676.16 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This competitive contract represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a ceiling value of $1,584.52. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW7BDelivery Order
The Defense Logistics Agency awarded a $2,376.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with a completion deadline of January 21, 2026. This non-set-aside contract was awarded on December 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply relationship with the federal government's primary medical procurement organization. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As the prime vendor under this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare systems worldwide, including specialized medications, brand-name and generic drugs, and related medical supplies. The company's selection as prime vendor reflects its demonstrated capability to meet federal procurement requirements through competitive award processes and to serve the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/28/25 |